Loading...
Loading...
Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio.
Cadence Pharmaceuticals Inc
CADX has a PEG ratio of 0.02. CADX's trailing-twelve-month revenue is $10.81 million.
Vertex Pharmaceuticals Incorporated
VRTX has a PEG ratio of 0.06. VRTX's trailing-twelve-month operating margin is 15.72%.
Exelixis Inc
EXEL has a PEG ratio of 0.08. EXEL had $223.16 million in total cash for the latest quarter.
Dendreon Corporation
DNDN has a PEG ratio of 0.17. DNDN's trailing-twelve-month revenue is $164.48 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in